OptimiTM-03.jpg
Optimi Health Submits Phase I Clinical Trial Application Combining The Use Of Proprietary Psilocybin and MDMA Drug Candidates In Healthy Therapists
February 07, 2023 10:31 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end Canadian-based drug manufacturer...
OptimiTM-03.jpg
Optimi Health Completes First Production of Novel MDMA Drug Candidate OPTI-MHCL
February 06, 2023 08:30 ET | Optimi Health Corp.
The Company is producing OPTI-MHCL in-house under its Health Canada issued Dealers Licence using Optimi’s scalable, proprietary production method. Optimi is also manufacturing MDMA under...
Optimi Health Expands Functional Mushroom Sales Network With Additional Brokers, Distribution Agreements
January 17, 2023 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end Canadian-based drug manufacturer...
OptimiTM-03.jpg
Optimi Health Announces Re-Appointments to Board of Directors
January 10, 2023 16:15 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that Mr. Bryan Safarik,...
OptimiTM-03.jpg
Alberta Puts Patients First By Regulating Psychedelic Therapy: Optimi Health
October 06, 2022 12:51 ET | Optimi Health Corp.
Highlights: The safe supply of psychedelic drug products manufactured at a GMP-level is critical in treating serious mental health issues. Minister of Mental Health and Addictions, the Honourable...
OptimiTM-03.jpg
Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History
September 08, 2022 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed...
OptimiTM-03.jpg
Optimi Health Provides Progress Report On Year Of Commercialization
September 01, 2022 09:00 ET | Optimi Health Corp.
Company set to introduce psychedelic product catalogue showcasing in-house EU-GMP manufacturing expertise VANCOUVER, British Columbia, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE:...
Justin Kirkland_BW
Optimi Health Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics
June 20, 2022 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, June 20, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...